COMPANY

Building the photomedicine platform

Our purpose, our people, and the road ahead.

OUR PURPOSE

Medicine, delivered as light.

Photomedicine uses precise wavelengths of light to restore how cells produce energy, calm inflammation, and regulate the nervous system — non-invasively, without drugs or surgery. We believe it is one of the most underexploited frontiers in modern medicine.

MISSION

To advance non-invasive photomedicine — wearable photo-neuromodulation and portable therapeutic lasers — and translate it into tangible benefits for patients.

VISION

To build Joulez into an integrated platform uniting translational research, product development, and commercialization — driving progress across the entire photomedicine field.

CORE TEAM

Core Team

IL

Isaac Li

Founder & CEO

UVA BME · Yale MPH · PKU PhD (in progress)

TJ

Tan Jiaying

Co-founder & COO

PKU Engineering Mgmt · PKU PhD (in progress)

EH

Eden Huang

Head of Product

UMN Stats/Econ · Duke Stats · Liberty Mutual · Australis

QY

Qiu Yueqing

Head of Marketing

BNU Physics · MedSci · Brand builder

XY

Xie Yujun

Technical Advisor

Yale PhD (Mech Eng) · SJTU Assoc Prof · ex-IBM / LBNL

Backed by institutional investors and industry partners

DEVELOPMENT ROADMAP

Development Roadmap

A phased strategy: market entry → clinical validation → regulatory approvals → platform scale

2026 H1

Neuro Headband MVP finalized with app integration; consumer (non-medical) launch. Handheld HILT prototype — thermal + safety closed-loop. AI platform: device–app–cloud data pipeline live. Cartilage laser: import Class III registration initiated.

2026 H2

Headband NMPA Class II type-testing & registration filing. HILT safety / EMC testing & Class III filing. AI platform Beta with Bayesian tuning. Cartilage laser type-testing complete.

2027

Headband ASD / ADHD / MCI clinical trials advance toward Class II approval. HILT FDA registration & home-version design. AI home light therapy (lamp / mirror) defined and launched. Cartilage laser materials submitted.

2028

Headband new-indication filings, ASD / ADHD approval and Pro version (EEG). HILT home-version approval; dual-market scale-up. AI platform: RL model + SaaS scale-up. Cartilage laser import approval & domestic design.

2029

Headband medical product matrix. HILT stable growth. AI platform: platform-ization & open API output. Cartilage laser domestic Class III approval. Home light-therapy line expansion.